SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (5969)11/25/1998 7:45:00 PM
From: Bill Wexler  Read Replies (3) of 7041
 
The Zonagen fraud will eventually, and inevitably trade in the low single digits.

The reason there were no royalties from Mexico, quite simply, is because there were no significant sales in Mexico. This is not surprising, since there is no evidence that oral Phentolamine is effective for ED. Zonagen is closely associated to another Texas Biotechnology fraud: TXB. I correctly predicted that the FDA would reject TXB's drug candidate, Novastan and shorted the stock. Clueless was (and unbelievably still is) a big promoter of the stock:

Message 4374979
Message 4413217

Message 6564984

There is zero doubt that the FDA will reject the fraudulent "Vasomax" as well, sending the stock into the gutter. However, I caution short-sellers that the company has a long history of fraud and stock-manipuilation through false and misleading press releases. I have no doubt that hours or even minutes after FDA rejection, Zonagen will issue a press release stating that they intend to "refile"...following the same pattern as their partner in crime, TXB.

The Viagra news has absolutely no bearing on Zonagen. Viagra is a legitimate drug from a legitimate company. Vasomax is a worthless generic drug from a company run by crooked, filthy, lying bastards.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News